2022
DOI: 10.1016/j.bjorl.2020.07.011
|View full text |Cite
|
Sign up to set email alerts
|

Betahistine add-on therapy for treatment of subjects with posterior benign paroxysmal positional vertigo: a randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 19 publications
0
10
0
Order By: Relevance
“…In contrast, our research is the biggest randomized controlled trial to date examining the role of medicine in the management of persistent symptoms. We found that the participants in the (vestibular suppressor) group developed good effects of Epley's maneuvers than those in the no-medication group 23 . Also, dizziness was greatly reduced in those using vestibular suppressants.…”
Section: Discussionmentioning
confidence: 69%
“…In contrast, our research is the biggest randomized controlled trial to date examining the role of medicine in the management of persistent symptoms. We found that the participants in the (vestibular suppressor) group developed good effects of Epley's maneuvers than those in the no-medication group 23 . Also, dizziness was greatly reduced in those using vestibular suppressants.…”
Section: Discussionmentioning
confidence: 69%
“…Six articles [ 13 , 14 , 17 – 19 , 21 ] assessed the efficacy rate after treatment. The randomized-effects model analysis showed no significant difference was observed in efficiency rate between the 2 groups (RR = 1.07, 95% CI 0.99–1.16, P = .092) (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Five studies [13,[15][16][17]19] reported DHI score after treatment. The randomized-effects model was adopted, because of the significant heterogeneity (I 2 = 66.4%, P = .018).…”
Section: Dhi Scorementioning
confidence: 99%
See 2 more Smart Citations